Therapeutic vaccines play a crucial role in enhancing immune responses against various infectious diseases and cancer. Therapeutic vaccines aid in boosting the immune system’s ability to fight tumors or infections through antigen-specific immune responses. These vaccines can be designed to combat challenging pathogens or tumors that evade conventional vaccines by strengthening the body’s natural defenses. The therapeutic vaccines market caters to various diseases like infectious diseases, cancer, allergy & asthma, and others.
Market key trends:
The market is majorly driven by the rising prevalence of various chronic diseases globally. Therapeutic vaccines are beneficial in chronic diseases management as they enhance immunity against the causative pathogens or tumor antigens. According to the World Health Organization (WHO), chronic diseases are expected to account for almost three quarters of all deaths worldwide by 2030. The growing disease burden is raising demand for effective treatments like therapeutic vaccines for long term protection. Furthermore, ongoing research and clinical trials focused on expanding therapeutic vaccine applications in other indications like neurodegenerative disorders and autoimmune diseases are anticipated to open new lucrative opportunities over the forecast period. Partnerships between key players for vaccine development collaborations will also contribute to market growth.
Segment Analysis
The global therapeutic vaccines market is dominated by the infectious disease segment. This segment accounted for over 40% share of the global market in 2024 due to high disease prevalence of infectious diseases such as HIV, hepatitis, tuberculosis etc. The cancer segment is expected to witness fastest growth during the forecast period owing to increasing research efforts in the area of therapeutic cancer vaccines and rising number of clinical trials for novel cancer vaccines.
Key Takeaways
The Global Therapeutic Vaccines Market Demand is expected to witness high growth during the forecast period from 2024 to 2031.
Regional analysis
North America dominated the global market in 2024 and accounted for around 35% share. Presence of well-established pharmaceutical companies and growing biotechnology industry are major factors driving the market in the region. Europe was the second largest market in 2024 owing to increasing public and private funding for research and development of therapeutic vaccines. Asia Pacific is expected to witness fastest growth during the forecast period supported by rising healthcare spending, increasing government focus on immunization programs and presence of contract vaccine manufacturing facilities in major Asian countries.
Key players
Key players operating in the therapeutic vaccines market are AMR India Limited, Carmeuse, GLC Minerals LLC, Graymont Limited, Gujarat Mineral Development Corporation Ltd, Imerys, Kerford Limestone, LafargeHolcim, Lhoist Group, Minerals Technologies Inc., Okutama Kogyo Co. Ltd, Omya AG, RSMM Limited, Ryokolime Industry Co. Ltd (Mitsubishi Materials Corporation), SCHAEFER KALK GmbH & Co. KG, The National Lime & Stone Company, and United States Lime & Minerals Inc. The market is highly consolidated with top five players accounting for over 50% share in 2024. These players are focusing on new product launches, geographical expansion and acquisitions to gain maximum market share.
Explore more information on this topic, Please visit -
https://www.insightprobing.com/therapeutic-vaccines-market-size-and-trends-analysis/
Explore more trending article related this topic -
https://www.pressreleasebulletin.com/biopharma-buffer-market-size-and-trends-analysis/
Comments
0 comment